CellSource , Ltd. Profit Margin

CellSource , Ltd.'s profit margin stands at 2.87% as of July 2026. That compares with -1.3% in the prior-year period — up 319.6% year over year. That is below the Healthcare sector average of 9.48%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

CellSource , Ltd. reported 2.87% in profit margin versus -1.3% a year earlier — a 319.6% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

CellSource , Ltd. sits lower the Healthcare benchmark (9.48%) with a profit margin of 2.87%. That is roughly 69.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 2.87% for CellSource , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how CellSource , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places 4880.T next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.